Invited commentary: Acne in adolescence - Protecting the heart but damaging the prostate later in life?

American Journal of Epidemiology

Volumn 161, Issue 12, 2005, Pages 1102-1106

  Ford, Earl S ^a,d   Liu, Simin ^b,c  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; TESTOSTERONE;

ADOLESCENCE; CARDIOVASCULAR DISEASE;

ACNE; ADOLESCENT; ADOLESCENT DISEASE; ADULT; AGED; CANCER RISK; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; CORONARY ARTERY DISEASE; CORONARY RISK; FEMALE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MALE GENITAL TRACT CANCER; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PROSTATE CANCER; SOCIOECONOMICS;

ACNE VULGARIS; ADOLESCENT; ADULT; AGE FACTORS; ANDROGENS; CAUSALITY; COMORBIDITY; CORONARY DISEASE; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEW ZEALAND; PROSTATIC NEOPLASMS; RISK FACTORS; SEX FACTORS; UNITED STATES;

EID: 20544465554     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwi148     Document Type: Note

References (52)

1. Savin JA. Osler and the skin. Br J Dermatol 2000;143:1-8.
2. Frank ST. Aural sign of coronary-artery disease. N Engl J Med 1973;289:327-8.
3. Rosenman RH, Brand RJ, Sholtz RI, et al. Relation of corneal arcus to cardiovascular risk factors and the incidence of coronary disease. N Engl J Med 1974;291:1322-4.
4. Herrera CR, Lynch C. Is baldness a risk factor for coronary artery disease? A review of the literature. J Clin Epidemiol 1990;43:1255-60.
5. Miric D, Fabijanic D, Giunio L, et al. Dermatological indicators of coronary risk: a case-control study. Int J Cardiol 1998;67:251-5.
6. Schnohr P, Lange P, Nyboe J, et al. Gray hair, baldness, and wrinkles in relation to myocardial infarction: the Copenhagen City Heart Study. Am Heart J 1995;130:1003-10.
7. Galobardes B, Davey Smith G, Jeffreys M, et al. Acne in adolescence and cause-specific mortality: lower coronary heart disease but higher prostate cancer mortality: the Glasgow Alumni Cohort Study. Am J Epidemiol 2005;161:1094-101.
8. Parnes HL, Thompson IM, Ford LG. Prevention of hormone-related cancers: prostate cancer. J Clin Oncol 2005;23:368-77.
9. Eaton NE, Reeves GK, Appleby PN, et al. Endogenous sex hormones and prostate cancer: a quantitative review of prospective studies. Br J Cancer 1999;80:930-4.
10. Shaneyfelt T, Husein R, Bubley G, et al. Hormonal predictors of prostate cancer: a meta-analysis. J Clin Oncol 2000;18: 847-53.
11. Malkin CJ, Pugh PJ, Jones RD, et al. Testosterone as a protective factor against atherosclerosis-immunomodulation and influence upon plaque development and stability. J Endocrinol 2003;178:373-80.
12. Wu FC, von Eckardstein A. Androgens and coronary artery disease. Endocr Rev 2003;24:183-217.
13. Muller M, van der Schouw YT, Thijssen JH, et al. Endogenous sex hormones and cardiovascular disease in men. J Clin Endocrinol Metab 2003;88:5076-86.
14. Phillips GB. Relationship between serum sex hormones and glucose, insulin, and lipid abnormalities in men with myocardial infarction. Proc Natl Acad Sci U S A 1977;74: 1729-33.
15. Lichtenstein MJ, Yarnell JW, Elwood PC, et al. Sex hormones, insulin, lipids, and prevalent ischemic heart disease. Am J Epidemiol 1987;126:647-57.
16. Seidell JC, Bjorntorp P, Sjostrom L, et al. Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels. Metabolism 1990;39:897-901.
17. Pasquali R, Casimirri F, Cantobelli S, et al. Effect of obesity and body fat distribution on sex hormones and insulin in men. Metabolism 1991;40:101-4.
18. Simon D, Preziosi P, Barrett-Connor E, et al. Interrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom Study. Diabetologia 1992;35:173-7.
19. Phillips GB. Relationship between serum sex hormones and the glucose-insulin-lipid defect in men with obesity. Metabolism 1993;42:116-20.
20. Haffner SM, Valdez RA, Mykkanen L, et al. Decreased testosterone and dehydroepiandrosterone sulfate concentrations are associated with increased insulin and glucose concentrations in nondiabetic men. Metabolism 1994;43:599-603.
21. Haffner SM, Karhapaa P, Mykkanen L, et al. Insulin resistance, body fat distribution, and sex hormones in men. Diabetes 1994;43:212-19.
22. Barrett-Connor E, Khaw KT. Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study. Circulation 1988;78:539-45.
23. Goodman-Gruen D, Barrett-Connor E. Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women. Diabetes Care 2000;23:912-18.
24. Chang TC, Tung CC, Hsiao YL. Hormonal changes in elderly men with non-insulin-dependent diabetes mellitus and the hormonal relationships to abdominal adiposity. Gerontology 1994;40:260-7.
25. Vermeulen A, Kaufman JM, Giagulli VA. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. J Clin Endocrinol Metab 1996;81:1821-6.
26. Haffner SM, Valdez RA, Stern MP, et al. Obesity, body fat distribution and sex hormones in men. Int J Obes Relat Metab Disord 1993;17:643-9.
27. Khaw KT, Barrett-Connor E. Lower endogenous androgens predict central adiposity in men. Ann Epidemiol 1992;2: 675-82.
28. Marin P, Krotkiewski M, Bjorntorp P. Androgen treatment of middle-aged, obese men: effects on metabolism, muscle and adipose tissues. Eur J Med 1992;1:329-36.
29. Simon D, Charles MA, Lahlou N, et al. Androgen therapy improves insulin sensitivity and decreases leptin level in healthy adult men with low plasma total testosterone: a 3-month randomized placebo-controlled trial. Diabetes Care 2001;24:2149-51.
30. Haffner SM, Dunn JF, Katz MS. Relationship of sex hormone-binding globulin to lipid, lipoprotein, glucose, and insulin concentrations in postmenopausal women. Metabolism 1992; 41:278-84.
31. Lapidus L, Lindstedt G, Lundberg PA, et al. Concentrations of sex-hormone binding globulin and corticosteroid binding globulin in serum in relation to cardiovascular risk factors and to 12-year incidence of cardiovascular disease and overall mortality in postmenopausal women. Clin Chem 1986;32: 146-52.
32. Birdsall MA, Farquhar CM, White HD. Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization. Ann Intern Med 1997; 126:32-5.
33. 4 in relation to ischemic heart disease mortality in diabetic subjects. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care 1996;19:1045-50.
34. Oh JY, Barrett-Connor E, Wedick NM, et al. Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo Study. Diabetes Care 2002;25:55-60.
35. Stellato RK, Feldman HA, Hamdy O, et al. Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts Male Aging Study. Diabetes Care 2000;23: 490-4.
36. Haffner SM, Shaten J, Stern MP, et al. Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Am J Epidemiol 1996;143:889-97.
37. Tibblin G, Adlerberth A, Lindstedt G, et al. The pituitary-gonadal axis and health in elderly men: a study of men born in 1913. Diabetes 1996;45:1605-9.
38. Feldman HA, Johannes CB, Araujo AB, et al. Low dehydro-epiandrosterone and ischemic heart disease in middle-aged men: prospective results from the Massachusetts Male Aging Study. Am J Epidemiol 2001;153:79-89.
39. Rebora A. Baldness and coronary artery disease: the dermatologic point of view of a controversial issue. Arch Dermatol 2001;137:943-7.
40. Ries LAG, Eisner MP, Kosary CL, et al, eds. SEER cancer statistics review, 1975-2001. Bethesda, MD: National Cancer Institute, 2004. (http://seer.cancer.gov/csr/1975_2001/).
41. Capewell S, Livingston BM, MacIntyre K, et al. Trends in case-fatality in 117 718 patients admitted with acute myocardial infarction in Scotland. Eur Heart J 2000;21: 1833-40.
42. Pillsbury DM, Shelley WB, Kligman AM. Acne, acneiform eruptions and rosacea. In: Textbook of acne: morphogenesis and treatment. Philadelphia, PA: WB Saunders, 1956.
43. Burke BM, Cunliffe WJ. The assessment of acne vulgaris-the Leeds technique. Br J Dermatol 1984;111:83-92.
44. Drake LA. Guidelines of care for acne vulgaris. J Am Acad Dermatol 1990;22:676-80.
45. Stathakis V, Kilkenny M, Marks R. Descriptive epidemiology of acne vulgaris in the community. Australas J Dermatol 1997;38:115-23.
46. Schafer T, Nienhaus A, Vieluf D, et al. Epidemiology of acne in the general population: the risk of smoking. Br J Dermatol 2001;145:100-4.
47. Lello J, Pearl A, Arroll B, et al. Prevalence of acne vulgaris in Auckland senior high school students. N Z Med J 1995;108: 287-9.
48. Magin P, Pond D, Smith W, et al. A systematic review of the evidence for 'myths and misconceptions' in acne management: diet, face-washing and sunlight. Fam Pract 2005;22: 62-70.
49. de Lorgeril M, Salen P. Alpha-linolenic acid and coronary heart disease. Nutr Metab Cardiovasc Dis 2004;14:162-9.
50. Astorg P. Dietary n-6 and n-3 polyunsaturated fatty acids and prostate cancer risk: a review of epidemiological and experimental evidence. Cancer Causes Control 2004;15:367-86.
51. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340: 1801-11.
52. Manson JE, Hsia J, Johnson KC, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003; 349:523-34.